UNSPSC 51312108: Olopatadine hydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C21H23NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2XG66W44KF, chemically known as 11-((z)-3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid but more generally known as olopatadine hydrochloride, which bears US NIH Compound Identifier 5281071. European Medicines Agency schedules Olopatadine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03509MIG.

UNSPSC 51312108 Olopatadine hydrochloride is a Commodity code that covers pharmaceutical products; however, the recent state and local procurement activity tagged under this code does not align with olopatadine, an antihistamine eye drop. Seminole County, Florida released IFB60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually—products unrelated to the code's nominal scope. The mismatch suggests either a data-tagging error in the source or misapplication of the code by the issuing jurisdiction. The code shows no relevant recent activity for olopatadine hydrochloride procurement by state and local governments in the available record.

Seminole County's naloxone and drug deactivation systems solicitation, while present in the data, does not represent legitimate purchasing activity under this Commodity code and should not be used as a basis for business development strategy in olopatadine products or antihistamines.